Lumen Technologies enters the final week of August with an unusual split in its positioning signals — options traders have turned sharply bullish just as short sellers quietly add to their bets.
The options market is sending its most aggressive call-side reading of the past year. The put/call ratio dropped to 0.52 on Tuesday — the lowest of the past 52 weeks and nearly three standard deviations below its 20-day average of 0.69. That kind of extreme call skew reflects genuine demand for upside exposure, not simply a retreat from put hedging. The move is all the more striking given that the stock has lost nearly 4% on the week and 7% over the past month, closing Tuesday at $5.89. Someone is buying calls into weakness.
Short interest tells a different story, and the contrast matters. Bears have been methodically rebuilding. Short interest climbed to 6.2% of the free float — up about 2.5% on the week and 3.3% over the past month — after dipping in mid-August from a recent high above 65 million shares. That is a genuine rebuilding pattern, not noise. The borrow market, however, gives shorts no particular urgency: availability is extremely loose at nearly 3,000% of outstanding short interest, meaning there are roughly 30 shares available to borrow for every one currently lent out. Borrowing costs remain almost negligible at 0.37%, down from a monthly high near 0.49%. The lending conditions simply do not reflect a crowded or pressured short — plenty of room for bears to grow their position without fighting for stock.
The Street's tone has soured since the most recent quarterly print. The August 4 results landed badly — the stock fell 5.7% the next day and never fully recovered. Goldman Sachs and Wells Fargo each trimmed their targets by roughly 14% the week of results, while Citigroup followed on August 11, cutting from $10 to $8.25 while keeping its Neutral rating. The consensus price target now sits at $7.64, implying about 30% upside from current levels — but given the direction of recent revisions, that gap reflects stale optimism as much as genuine conviction. Every active firm tracked here holds a Neutral or equivalent rating, a uniformly cautious stance that has not shifted in either direction. The EV/EBITDA multiple has crept up about 1.5% over 30 days to 7.7x, reflecting the price decline more than any fundamental re-rating. EPS surprise ranks in the 85th percentile, one of the few genuinely positive data points in the factor profile — Lumen has a habit of beating expectations even as the underlying business shrinks.
The CEO's recent move is worth noting. Kate Johnson bought 100,000 shares on August 6 at $6.13 — roughly $612,000 out of pocket — less than 48 hours after the stock dropped on earnings. It is her second open-market purchase this year, following a similar buy in early February near $6.35. The pattern of the CEO buying at these levels while simultaneously having sold a much larger block at $7.11 in late February creates an ambiguous picture; the purchases are supportive in tone but modest relative to her prior sales. Net insider buying over the past 90 days amounts to about 123,000 shares, skewed almost entirely by these two CEO purchases. There has been no follow-through from other insiders. BlackRock remains the dominant holder at nearly 14% of shares, and FMR added aggressively — buying nearly 14 million shares in the most recent filing period — but those positions were reported as of late July, before the August sell-off.
The next scheduled earnings event is November 3. Between now and then, the question is whether the extreme call-side positioning from this week was well-timed contrarianism or a short-lived technical move in a thinly traded options chain. With short interest still grinding higher and analysts uniformly sitting on the sidelines, the borrow market will be worth watching for any sign that availability begins to tighten — the one development that could change the character of the trade.
See the live data behind this article on ORTEX.
Open LUMN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
